Dr. Peter Marks emphasized the FDA's approval as a significant enhancement in vaccination accessibility, providing "a new option for receiving a safe and effective seasonal influenza vaccine potentially with greater convenience." He highlighted the importance of making vaccines more accessible, especially for busy families.